Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence
of antiphospholipid antibodies, such as lupus anticoagulant, anticardiolipin antibodies and …

Diagnosis of antiphospholipid syndrome (APS) requires the presence of a clinical criterion
(thrombosis and/or pregnancy morbidity), combined with persistently circulating …

Currently, we use the classification criteria for antiphospholipid syndrome (APS) formulated
during the consensus conference in Sapporo and revised in Sydney 1. Classification criteria …

Background Diagnosis of antiphospholipid syndrome (APS) requires persistent presence of
lupus anticoagulant (LAC), anticardiolipin (aCL) IgG/IgM, or anti‐β2 glycoprotein I (aβ2GPI) …

The effect of additional treatments combined with conventional therapy on pregnancy
outcomes was examined in high-risk primary antiphospholipid syndrome (PAPS) patients to …

Background The antiphospholipid syndrome (APS) is characterized by thrombosis and/or
pregnancy morbidity with the persistent presence of lupus anticoagulant (LAC), anti …

Hemostasis is a complex but balanced process that permit normal blood flow, without
adverse events. Disruption of the balance may lead to bleeding or thrombotic events, and …

The laboratory criteria that define patients with antiphospholipid syndrome (APS) include
lupus anticoagulant (LAC), anticardiolipin antibodies and anti‐β2 glycoprotein I antibodies …

Background Antiβ2glycoprotein I (aβ2GPI) and anticardiolipin (aCL) IgG/IgM show
differences in positive/negative agreement and titers between solid phase platforms. Method …

Abstract Purpose of the Review This review focuses on the laboratory tests necessary for the
diagnosis of antiphospholipid syndrome (APS). For the interpretation of the results of the …